Announcement on Conversion Result of Convertible Bonds and Share Changes
Securities code: 603077 Securities abbreviation: Hebang Biotechnology Announcement number: 2026-054 Bond code: 113691 Bond abbreviation: Hebang Convertible Bonds
Sichuan Hebang Biotechnology Co., Ltd.
Announcement on Convertible Bonds Conversion Results and Share Changes
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
● Cumulative stock conversion situation: As of June 30, 2026, the cumulative conversion amount of the convertible bonds "Hebang Convertible Bonds" of Sichuan Hebang Biotechnology Co., Ltd. (hereinafter referred to as the "Company" and the "Company") was 905,000 yuan, and the cumulative number of shares formed due to the conversion was 452,500 shares, accounting for 0.0051% of the company's total issued shares before the convertible bonds were converted.
● Convertible bonds that have not been converted into shares: As of June 30, 2026, the amount of "Hebang Convertible Bonds" that have not been converted into shares is 4,599,095,000 yuan, accounting for 99.9803% of the total amount of convertible bonds issued.
● Share conversion situation in this quarter: From April 1, 2026 to June 30, 2026, the conversion amount of "Hebang Convertible Bonds" was 60,000 yuan, and the number of shares formed due to the conversion was 30,000 shares.
1. Overview of issuance and listing of convertible bonds
With the approval and registration of China Securities Regulatory Commission's Securities Regulatory Commission [2024] No. 1233, the company issued 46 million convertible corporate bonds to unspecified objects on October 28, 2024, with a face value of 100.00 yuan each, and a total issuance of 460,000.00 Ten thousand yuan, the bond term is 6 years, and the coupon rate of this issuance is: 0.30% in the first year, 0.50% in the second year, 1.00% in the third year, 1.50% in the fourth year, 1.80% in the fifth year, and 2.00% in the sixth year.
As approved by the Shanghai Stock Exchange's Self-Regulation Decision [2024] No. 153, the company's 4.6 billion yuan convertible corporate bonds issued this time will be listed and traded on the Shanghai Stock Exchange on November 19, 2024. The bond abbreviation is "Hebang Convertible Bonds" and the bond code is "113691".
According to the relevant provisions of the "Stock Listing Rules of the Shanghai Stock Exchange" and the "Prospectus for the Issuance of Convertible Corporate Bonds by Sichuan Hebang Biotechnology Co., Ltd. to Unspecified Targets", the "Hebang Convertible Bonds" issued by the company can be converted into shares of the company starting from May 6, 2025, with a conversion price of 2.00 yuan per share.
2. The current conversion situation of convertible bonds
(1) The conversion period of "Hebang Convertible Bonds" starts from May 6, 2025 and ends on October 27, 2030. As of June 30, 2026, the cumulative amount of stock conversions was 905,000 yuan, and the cumulative number of shares formed due to stock conversions was 452,500 shares, accounting for 0.0051% of the company's total issued shares before the convertible bonds were converted. Among them, from April 1, 2026 to June 30, 2026, the conversion amount of "Hebang Convertible Bonds" was 60,000 yuan, and the number of shares formed due to the conversion was 30,000 shares.
(2) As of June 30, 2026, the amount of "Hebang Convertible Bonds" that have not yet been converted into shares is 4,599,095,000 yuan, accounting for 99.9803% of the total amount of convertible bonds issued.
3. Changes in share capital
Unit: Before share change Share class after change This convertible bond conversion
(March 31, 2026) (June 30, 2026) Circulating shares with trading restrictions 0 0 0 Circulating shares without trading restrictions 8,831,672,728 30,000 8,831,702,728 Total share capital 8,831,672,728 30,000 8,831,702,728
4. Others
If investors need to know the specific situation of "Hebang Convertible Bonds", please refer to the "Prospectus for the Issuance of Convertible Corporate Bonds by Sichuan Hebang Biotechnology Co., Ltd. to Unspecified Targets" disclosed by the company on the website of the Shanghai Stock Exchange on October 24, 2024.
Contact Department: Office of the Company’s Board of Directors
Contact number: 028-6205 0230
Announcement is hereby made.
Board of Directors of Sichuan Hebang Biotechnology Co., Ltd.
July 2, 2026